XML 41 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash The following represents a reconciliation of cash and cash equivalents in the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the unaudited condensed consolidated statements of cash flows:
In millions
June 30,
2019
    
December 31,
2018
Cash and cash equivalents
$
6,063

 
$
4,059

Restricted cash (included in other current assets)
6

 
6

Restricted cash (included in other assets)
269

 
230

Total cash, cash equivalents and restricted cash in the statements of cash flows
$
6,338

 
$
4,295

 
 
 
 

Accounts Receivable, Net Accounts receivable, net is composed of the following:
In millions
June 30,
2019
    
December 31,
2018
Trade receivables
$
6,966

 
$
6,896

Vendor and manufacturer receivables
8,358

 
7,655

Premium receivables
2,098

 
2,259

Other receivables
752

 
821

   Total accounts receivable, net
$
18,174

 
$
17,631

 
 
 
 

Disaggregation of Revenue
The following tables disaggregate the Company’s revenue by major source in each segment for the three and six months ended June 30, 2019 and 2018:
 
Pharmacy
 
Retail/
 
Health Care
 
Corporate/
 
Intersegment
 
Consolidated
In millions
Services
    
LTC
    
Benefits
 
Other
 
Eliminations
    
Totals
Three Months Ended June 30, 2019
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
34,698

 
$
16,392

 
$

 
$

 
$
(10,422
)
 
$
40,668

Front Store

 
4,875

 

 

 

 
4,875

Premiums

 

 
15,777

 
14

 

 
15,791

Net investment income

 

 
148

 
145

 

 
293

Other
144

 
180

 
1,478

 
2

 

 
1,804

Total
$
34,842

 
$
21,447

 
$
17,403

 
$
161

 
$
(10,422
)
 
$
63,431

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
22,028

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
12,670

 
 
 
 
 
 
 
 
 
 
Other
144

 
 
 
 
 
 
 
 
 
 
Total
$
34,842

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
33,293

 
$
15,805

 
$

 
$

 
$
(8,151
)
 
$
40,947

Front Store

 
4,707

 

 

 

 
4,707

Premiums

 

 
751

 

 

 
751

Net investment income

 

 
4

 
210

 

 
214

Other
134

 
160

 
9

 

 

 
303

Total
$
33,427

 
$
20,672

 
$
764

 
$
210

 
$
(8,151
)
 
$
46,922

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
21,506

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
11,787

 
 
 
 
 
 
 
 
 
 
Other
134

 
 
 
 
 
 
 
 
 
 
Total
$
33,427

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category.
(2)
Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a CVS Pharmacy retail store, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.

 
Pharmacy
 
Retail/
 
Health Care
 
Corporate/
 
Intersegment
 
Consolidated
In millions
Services
    
LTC
    
Benefits
 
Other
 
Eliminations
    
Totals
Six Months Ended June 30, 2019
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
68,111

 
$
32,510

 
$

 
$

 
$
(21,429
)
 
$
79,192

Front Store

 
9,674

 

 

 

 
9,674

Premiums

 

 
32,036

 
37

 

 
32,073

Net investment income

 

 
312

 
230

 

 
542

Other
289

 
378

 
2,925

 
4

 

 
3,596

Total
$
68,400

 
$
42,562

 
$
35,273

 
$
271

 
$
(21,429
)
 
$
125,077

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
43,602

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
24,509

 
 
 
 
 
 
 
 
 
 
Other
289

 
 
 
 
 
 
 
 
 
 
Total
$
68,400

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
65,699

 
$
31,305

 
$

 
$

 
$
(16,752
)
 
$
80,252

Front Store

 
9,433

 

 

 

 
9,433

Premiums

 

 
2,057

 

 

 
2,057

Net investment income

 

 
6

 
258

 

 
264

Other
274

 
366

 
19

 

 

 
659

Total
$
65,973

 
$
41,104

 
$
2,082

 
$
258

 
$
(16,752
)
 
$
92,665

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
42,704

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
22,995

 
 
 
 
 
 
 
 
 
 
Other
274

 
 
 
 
 
 
 
 
 
 
Total
$
65,973

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category.
(2)
Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a CVS Pharmacy retail store, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.
Contracts With Customers, Assets and Liabilities
The following table provides information about receivables and contract liabilities from contracts with customers:
 
 
 
 
In millions
June 30,
2019
    
December 31,
2018
Trade receivables (included in accounts receivable, net)
$
6,966

 
$
6,896

Contract liabilities (included in accrued expenses)
76

 
67

 
 
 
 

During the six months ended June 30, 2019, the contract liabilities balance includes increases related to customers’ earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:
 
 
In millions
 
Balance at December 31, 2018
$
67

Loyalty program earnings and gift card issuances
181

Redemption and breakage
(172
)
Balance at June 30, 2019
$
76

 
 

Impact of New Lease Standard on Balance Sheet Line Items
As a result of applying the new lease standard using a modified retrospective method, the following adjustments were made to accounts on the condensed consolidated balance sheet as of January 1, 2019:
 
 
Impact of Change in Accounting Policy
 
    
As Reported
    
 
    
Adjusted
In millions
 
December 31, 2018
 
Adjustments
 
January 1, 2019
Condensed Consolidated Balance Sheets:
 
 
 
 
 
 
Other current assets
 
$
4,581

 
$
(48
)
 
$
4,533

Total current assets
 
45,243

 
(48
)
 
45,195

Property and equipment, net
 
11,349

 
11

 
11,360

Operating lease right-of-use assets
 

 
20,987

 
20,987

Intangible assets, net
 
36,524

 
(217
)
 
36,307

Other assets
 
5,046

 
(521
)
 
4,525

Total assets
 
196,456

 
20,212

 
216,668

Accrued expenses
 
10,711

 
(52
)
 
10,659

Current portion of operating lease liabilities
 

 
1,803

 
1,803

Current portion of long-term debt
 
1,265

 
2

 
1,267

Total current liabilities
 
44,009

 
1,753

 
45,762

Long-term operating lease liabilities
 

 
18,832

 
18,832

Long-term debt
 
71,444

 
(96
)
 
71,348

Deferred income taxes
 
7,677

 
63

 
7,740

Other long-term liabilities
 
2,780

 
(518
)
 
2,262

Total liabilities
 
137,913

 
20,034

 
157,947

Retained earnings
 
40,911

 
178

 
41,089

Total CVS Health shareholders’ equity
 
58,225

 
178

 
58,403

Total shareholders’ equity
 
58,543

 
178

 
58,721